181 related articles for article (PubMed ID: 21941058)
1. A study of drug-drug interactions in cancer patients of a south Indian tertiary care teaching hospital.
Kannan G; Anitha R; Rani VN; Thennarasu P; Alosh J; Vasantha J; Martin JR; Uma MR
J Postgrad Med; 2011; 57(3):206-10. PubMed ID: 21941058
[TBL] [Abstract][Full Text] [Related]
2. A prospective observational study of medication errors in general medicine department in a tertiary care hospital.
Karthikeyan M; Lalitha D
Drug Metabol Drug Interact; 2013; 28(1):13-21. PubMed ID: 23314531
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
4. Potentially inappropriate medication use in elderly patients: a study of prevalence and predictors in two teaching hospitals.
Harugeri A; Joseph J; Parthasarathi G; Ramesh M; Guido S
J Postgrad Med; 2010; 56(3):186-91. PubMed ID: 20739763
[TBL] [Abstract][Full Text] [Related]
5. Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals.
Harugeri A; Parthasarathi G; Ramesh M; Guido S; Basavanagowdappa H
J Postgrad Med; 2011; 57(3):189-95. PubMed ID: 21941055
[TBL] [Abstract][Full Text] [Related]
6. EPICC study: evaluation of pharmaceutical intervention in cancer care.
Vantard N; Ranchon F; Schwiertz V; Gourc C; Gauthier N; Guedat MG; He S; Kiouris E; Alloux C; You B; Souquet PJ; Freyer G; Salles G; Trillet-Lenoir V; Rioufol C
J Clin Pharm Ther; 2015 Apr; 40(2):196-203. PubMed ID: 25594148
[TBL] [Abstract][Full Text] [Related]
7. Potential drug interactions and duplicate prescriptions among cancer patients.
Riechelmann RP; Tannock IF; Wang L; Saad ED; Taback NA; Krzyzanowska MK
J Natl Cancer Inst; 2007 Apr; 99(8):592-600. PubMed ID: 17440160
[TBL] [Abstract][Full Text] [Related]
8. Drug interactions in cancer therapy.
Scripture CD; Figg WD
Nat Rev Cancer; 2006 Jul; 6(7):546-58. PubMed ID: 16794637
[TBL] [Abstract][Full Text] [Related]
9. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India.
Harugeri A; Joseph J; Parthasarathi G; Ramesh M; Guido S
Am J Geriatr Pharmacother; 2010 Jun; 8(3):271-80. PubMed ID: 20624616
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug events identified by triggers at a teaching hospital in Brazil.
Giordani F; Rozenfeld S; Martins M
BMC Pharmacol Toxicol; 2014 Dec; 15():71. PubMed ID: 25496209
[TBL] [Abstract][Full Text] [Related]
11. Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients.
Lemachatti J; Levêque D; Beretz L; Bergerat JP
Anticancer Res; 2009 Nov; 29(11):4741-4. PubMed ID: 20032429
[TBL] [Abstract][Full Text] [Related]
12. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
Jose J; Rao PG
Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
[TBL] [Abstract][Full Text] [Related]
13. Potential drug-drug interactions at a referral hematology-oncology ward in Iran: a cross-sectional study.
Hadjibabaie M; Badri S; Ataei S; Moslehi AH; Karimzadeh I; Ghavamzadeh A
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1619-27. PubMed ID: 23589317
[TBL] [Abstract][Full Text] [Related]
14. Assessment of quality of life of cancer patients in a tertiary care hospital of South India.
Kannan G; Rani V; Ananthanarayanan RM; Palani T; Nigam N; Janardhan V; Reddy UM
J Cancer Res Ther; 2011; 7(3):275-9. PubMed ID: 22044807
[TBL] [Abstract][Full Text] [Related]
15. Potential interactions with anticancer agents: a cross-sectional study.
Mouzon A; Kerger J; D'Hondt L; Spinewine A
Chemotherapy; 2013; 59(2):85-92. PubMed ID: 23881290
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy.
Ismail M; Khan S; Khan F; Noor S; Sajid H; Yar S; Rasheed I
BMC Cancer; 2020 Apr; 20(1):335. PubMed ID: 32307008
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
[TBL] [Abstract][Full Text] [Related]
18. Potential for drug interactions in hospitalized cancer patients.
Riechelmann RP; Moreira F; Smaletz O; Saad ED
Cancer Chemother Pharmacol; 2005 Sep; 56(3):286-90. PubMed ID: 15731916
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital.
Cruciol-Souza JM; Thomson JC
J Pharm Pharm Sci; 2006; 9(3):427-33. PubMed ID: 17207423
[TBL] [Abstract][Full Text] [Related]
20. Potential drug-drug interactions in hospitalized patients undergoing systemic chemotherapy: a prospective cohort study.
Stoll P; Kopittke L
Int J Clin Pharm; 2015 Jun; 37(3):475-84. PubMed ID: 25711852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
